Picture of CSPC Pharmaceutical logo

1093 CSPC Pharmaceutical Cashflow Statement

0.000.00%
hk flag iconLast trade - 00:00
HealthcareAdventurousLarge CapContrarian

Annual cashflow statement for CSPC Pharmaceutical, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.

2019
December 31st
2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
Period Length:12 M12 M12 M12 M
Source:ARSARSARSARS
Standards:
HKAS
HKAS
HKAS
HKAS
Status:FinalFinalFinalFinal
fx
Preliminary
Net Income/Starting Line4,6266,3916,8477,582
Depreciation
Amortisation
Non-Cash Items-150-1,078-545-465
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital-1,384619-2,529-536
Change in Accounts Receivable
Change in Inventories
Change in Other Assets
Change in Accounts Payable
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities3,7846,7404,6377,627
Capital Expenditures-2,123-1,577-1,758-2,723
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items-335-5531,121-4,073
Acquisition of Business
Sale of Business
Sale of Fixed Assets
Sale/Maturity of Investment
Change in Net Investments
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities-2,457-2,130-637-6,796
Financing Cash Flow Items-1,591-20-20.2342
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities-1,546-1,471-2,197-1,904
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash-2173,1411,800-1,059